Xeroderma pigmentosum (XP) is an ultraviolet light-sensitivity syndrome caused by nucleotide excision repair (NER) defects, resulting in hyperpigmentation and an increased incidence of skin cancer. These symptoms also characterize the skin ‘telopathies’, which result from accelerated telomere shortening and exhaustion of the regenerative capacity of stem cells and lead to premature death. In this issue, Gerdine Stout and Maria Blasco investigate the pathways that connect stem cell dysfunction with telomere uncapping using a mouse model of telomere dysfunction which phenocopies the symptoms of XP patients. They demonstrate that both the absence of NER and the abrogation of p53 activity restore stem cell functionality. This work highlights the relationship between telomeres and stem cell renewal with the pathobiology of cancer.
Telomere dysfunction in cancer and skin disease
Telomere dysfunction in cancer and skin disease. Dis Model Mech 25 February 2009; 2 (3-4): 93. doi:
Download citation file:
Advertisement
Cited by
DMM Journal Meeting 2024: Pre-clinical Modelling of Human Genetic Disease and Therapy

Registration is now open for our 2024 Journal Meeting. Rapid advances in gene editing and genetic technologies have revolutionised our ability to model human genetic disease and provided new hope for gene therapies. At this Meeting, we will present the very latest advances in modelling human genetic disease.
Moving towards heart success – Disease Models & Mechanisms Special Issue

DMM's most recent special issue compiles articles that aim to move heart failure to heart success by fundamentally addressing the roots of failure to identify curative strategies.
Crossroads in Virology

Our October Editorial written by Sumana Sanyal emphasises the urgency of a concerted effort in understanding virus–host interactions to inform the development of therapeutics and vaccines, helping to predict disease outcomes. Read the full Editorial here.
A Model for Life - an interview with Professor Kiran Musunuru




Read our new A Model for Life interview with Kiran Musunuru. Prof Musunuru investigates the mechanisms of disease in model systems, with the ultimate goal of developing innovative gene editing therapies.
Sustainable Conferencing Initiative

Through our Sustainable Conferencing Grants, we promote the use of new technology and greener modes of travel. Our blog posts showcase examples of sustainability in action and share experience about how new technologies and conference formats work in practice.
Other journals from
The Company of Biologists